TWIST BIOSCIENCE CORP's ticker is TWST and the CUSIP is 90184D100. A total of 237 filers reported holding TWIST BIOSCIENCE CORP in Q1 2021. The put-call ratio across all filers is 1.34 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $8,896,591 | +1.6% | 439,121 | +2.6% | 0.03% | +3.7% |
| Q2 2023 | $8,758,046 | +212.5% | 428,057 | +130.3% | 0.03% | +170.0% |
| Q1 2023 | $2,802,889 | +89.6% | 185,868 | +199.3% | 0.01% | +100.0% |
| Q4 2022 | $1,478,673 | +225.0% | 62,103 | +573.1% | 0.01% | +150.0% |
| Q1 2022 | $455,000 | -35.9% | 9,226 | +0.6% | 0.00% | 0.0% |
| Q4 2021 | $710,000 | -14.9% | 9,167 | +17.5% | 0.00% | -33.3% |
| Q3 2021 | $834,000 | +101.9% | 7,803 | +151.5% | 0.00% | +200.0% |
| Q2 2021 | $413,000 | -14.7% | 3,103 | -20.6% | 0.00% | -50.0% |
| Q1 2021 | $484,000 | -87.3% | 3,909 | -85.5% | 0.00% | -88.2% |
| Q4 2020 | $3,810,000 | +161.7% | 26,963 | +40.7% | 0.02% | +183.3% |
| Q3 2020 | $1,456,000 | +477.8% | 19,163 | +59.7% | 0.01% | +500.0% |
| Q4 2019 | $252,000 | -29.6% | 12,000 | -20.0% | 0.00% | 0.0% |
| Q3 2019 | $358,000 | – | 15,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tao Capital Management LP | 1,104,214 | $156,015,000 | 38.36% |
| Blue Water Life Science Advisors, LP | 146,356 | $20,678,000 | 6.16% |
| Casdin Capital, LLC | 1,000,000 | $141,290,000 | 4.19% |
| BRANDYWINE MANAGERS, LLC | 18,988 | $2,683,000 | 3.69% |
| Capital Impact Advisors, LLC | 97,000 | $13,705,000 | 3.36% |
| Brevan Howard Capital Management LP | 112,000 | $15,824,000 | 3.17% |
| ARK Investment Management | 5,876,971 | $830,357,000 | 2.21% |
| Nicholas Investment Partners, LP | 178,875 | $25,273,000 | 1.95% |
| Nikko Asset Management Americas, Inc. | 1,840,306 | $260,017,000 | 1.48% |
| Intellectus Partners, LLC | 28,058 | $3,964,000 | 1.19% |